Pexiganan vs Tyrocidine — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Pexiganan (MSI-78) is a synthetic analog of magainin-2, optimized for enhanced broad-spectrum antimicrobial activity and reduced hemolytic toxicity. It was developed by Magainin Pharmaceuticals (later Genaera) as a topical treatment for mildly infected diabetic foot ulcers....
Calculate Pexiganan dose →Tyrocidine A is a cyclic decapeptide component of tyrothricin, one of the first antibiotic mixtures produced commercially. Isolated from Bacillus brevis soil bacteria, tyrocidines are non-ribosomally synthesized peptides that disrupt bacterial membranes through a carpet mechanism...
Calculate Tyrocidine dose →| Parameter | Pexiganan | Tyrocidine |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Phase 3 (Failed 1999) | Preclinical |
| Half-Life | Hours (topical) | Short |
| Typical Dose | 0.8% cream topically | N/A (component of tyrothricin) |
| Frequency | Twice daily | N/A |
| Route | Topical cream | Topical (historical) |
| FDA Status | Not approved (failed Phase 3) | Not approved (part of historical tyrothricin) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.